225 related articles for article (PubMed ID: 22849267)
1. Antimicrobial agents targeting bacterial cell walls and cell membranes.
Bush K
Rev Sci Tech; 2012 Apr; 31(1):43-56. PubMed ID: 22849267
[TBL] [Abstract][Full Text] [Related]
2. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.
Malanovic N; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):936-46. PubMed ID: 26577273
[TBL] [Abstract][Full Text] [Related]
3. β-Lactam and glycopeptide antibiotics: first and last line of defense?
Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
[TBL] [Abstract][Full Text] [Related]
4. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
5. Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects.
Schuerholz T; Dömming S; Hornef M; Dupont A; Kowalski I; Kaconis Y; Heinbockel L; Andrä J; Garidel P; Gutsmann T; David S; Sánchez-Gómez S; Martinez de Tejada G; Brandenburg K
Curr Drug Targets; 2012 Aug; 13(9):1131-7. PubMed ID: 22664073
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptides: Cell Membrane and Microbial Surface Interactions.
Lohner K; Hilpert K
Biochim Biophys Acta; 2016 May; 1858(5):915-7. PubMed ID: 26965988
[No Abstract] [Full Text] [Related]
7. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria.
Chung PY; Khanum R
J Microbiol Immunol Infect; 2017 Aug; 50(4):405-410. PubMed ID: 28690026
[TBL] [Abstract][Full Text] [Related]
8. Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.
Niu Y; Padhee S; Wu H; Bai G; Qiao Q; Hu Y; Harrington L; Burda WN; Shaw LN; Cao C; Cai J
J Med Chem; 2012 Apr; 55(8):4003-9. PubMed ID: 22475244
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
Arhin FF; Belley A; McKay GA; Moeck G
Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224
[TBL] [Abstract][Full Text] [Related]
10. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
[TBL] [Abstract][Full Text] [Related]
11. Biological and structural effects of the conjugation of an antimicrobial decapeptide with saturated, unsaturated, methoxylated and branched fatty acids.
Húmpola MV; Rey MC; Carballeira NM; Simonetta AC; Tonarelli GG
J Pept Sci; 2017 Jan; 23(1):45-55. PubMed ID: 28025839
[TBL] [Abstract][Full Text] [Related]
12. Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.
Yarlagadda V; Samaddar S; Paramanandham K; Shome BR; Haldar J
Angew Chem Int Ed Engl; 2015 Nov; 54(46):13644-9. PubMed ID: 26473305
[TBL] [Abstract][Full Text] [Related]
13. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?
Ortwine JK; Werth BJ; Sakoulas G; Rybak MJ
Drug Resist Updat; 2013; 16(3-5):73-9. PubMed ID: 24268586
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded.
Ginsburg I
Med Hypotheses; 2004; 62(3):367-74. PubMed ID: 14975505
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci.
Mlynarczyk A; Mlynarczyk B; Kmera-Muszynska M; Majewski S; Mlynarczyk G
Mini Rev Med Chem; 2009 Nov; 9(13):1527-37. PubMed ID: 20205634
[TBL] [Abstract][Full Text] [Related]
16. New antimicrobial agents for the treatment of Gram-positive bacterial infections.
Aksoy DY; Unal S
Clin Microbiol Infect; 2008 May; 14(5):411-20. PubMed ID: 18261129
[TBL] [Abstract][Full Text] [Related]
17. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.
Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S
ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of membrane targeting antibiotics.
Epand RM; Walker C; Epand RF; Magarvey NA
Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
van Harten RM; Willems RJL; Martin NI; Hendrickx APA
Trends Microbiol; 2017 Jun; 25(6):467-479. PubMed ID: 28209400
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of resistance to beta-lactam antibiotics].
Heesemann J
Infection; 1993; 21 Suppl 1():S4-9. PubMed ID: 8314292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
